Crucell makes bid for vaccine maker
|
DEALS |
|||
|
WHO |
WITH |
WHAT |
SCOOP |
|
Crucell |
Berna Biotech |
$449 million buyout offer |
Crucell is making a bid to become the leading independent vaccine player in the world. |
|
Cephalon |
Zeneus Pharma |
$360 million acquisition |
The acquisition spurs Cephalon's entry into the European oncology market. |
|
Phase III Medical |
Neostem |
Acquisition |
Phase III gains a company that specializes in the collection and storage of adult stem cells. |
|
Matrix Laboratories |
Concord Biotech |
Acquisition of majority stake |
Concord has fermentation and bio-catalytic technology capabilities. |
|
Molecular Pharmacology |
Molecular Pharmacology Limited |
Acquisition |
The acquisition of MPL Australia will provide MPL USA a broader international arena. |